PUBLISHER: Allied Market Research | PRODUCT CODE: 1566929
PUBLISHER: Allied Market Research | PRODUCT CODE: 1566929
Acute Ischemic Stroke Diagnosis Market By Technology , By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
Acute Ischemic Stroke Diagnosis Market
The acute ischemic stroke diagnosis market was valued at $2.1 billion in 2023 and is projected to reach $3.6 billion by 2033, growing at a CAGR of 5.7% from 2024 to 2033.
Acute ischemic stroke (AIS) is a fatal condition that includes abrupt obstruction of blood flow to the brain, leading to neurological dysfunction. The blockage is typically caused due to a thrombus or embolus, resulting in brain tissue ischemia and infarction. Sudden weakness, difficulty speaking or understanding speech, numbness on one side of the body, vision problems, severe headaches, and dizziness are the most common symptoms of AIS. Immediate diagnosis for the condition involves clinical assessment and neuroimaging via CT or MRI, which is pivotal to timely restore the blood flow and reduce brain damage.
Increase in the prevalence of AIS, particularly in the elderly population, is boosting the demand for acute ischemic stroke diagnosis. The elderly population is growing exponentially across the globe and dynamic changes in lifestyle are leading to rise in the occurrence of life-threatening conditions among them. Moreover, surge in expenditure on healthcare and diagnostic technologies is a key driver of the market. Non-invasive imaging techniques such as arterial spin labeling are trending for the diagnosis of AIS in recent times. Such techniques enable measurement of cerebral blood flow non-invasively, hence helping to assess the tissue viability with quick & precise diagnosis.
However, the expense associated with such cutting-edge diagnosis techniques is significantly high which prevents the low-income population from leveraging its benefits, hence hampering the market development. Moreover, the reimbursement landscape for acute ischemic stroke diagnosis is highly inconsistent and challenging, thereby restricting the growth of the market. On the contrary, the consistent efforts by government to reduce the prevalence of AIS is anticipated to present lucrative opportunities for the market. For instance, the European Stroke Organization began an initiative called Stroke Action Plan for Europe in 2018 which aims to improve the preventive action for stroke until 2030.
Segment Review
The acute ischemic stroke diagnosis market is segmented into technology, end user, and region. On the basis of technology, the market is divided into computed tomography, magnetic resonance imaging, carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others. Depending on end user, it is classified into hospitals & clinics, ambulatory surgery centers, diagnostic laboratories and imaging centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of technology, the computed tomography segment acquired high stakes at the market in 2023.
Depending on end user, the hospitals & clinics segment was the highest shareholder in 2023.
Region wise, North America is poised to be the highest revenue generator by 2023.
Competition Analysis
The major players operating in the global acute ischemic stroke diagnosis market include Koninklijke Philips N.V., GE Healthcare, Canon Inc., Simens, Terumo Corporation, Stryker, Fujifilm Holdings Corporation, Samsung Electronics Co. Ltd, F. Hoffmann-La Roche Ltd, and Boehringer Ingelheim International GmbH. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
Key Market Segments
By Technology
- Computed Tomography
- Magnetic Resonance Imaging
- Carotid Ultrasound
- Cerebral Angiography
- Electrocardiography
- Echocardiography
- Others
By End User
- Hospitals and Clinics
- Ambulatory Surgery Centers
- Diagnostic Laboratories and Imaging Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players:
- Koninklijke Philips N.V.
- GE Healthcare
- Canon Inc.
- Simens
- Terumo Corporation
- Stryker
- Fujifilm Holdings Corporation
- Samsung Electronics Co. Ltd
- F. Hoffmann-La Roche Ltd
- Boehringer Ingelheim International GmbH
TABLE OF CONTENTS
CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
CHAPTER 4: ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Technology
- 4.2. Computed Tomography
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Magnetic Resonance Imaging
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. Carotid Ultrasound
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
- 4.5. Cerebral Angiography
- 4.5.1. Key Market Trends, Growth Factors and Opportunities
- 4.5.2. Market Size and Forecast, By Region
- 4.5.3. Market Share Analysis, By Country
- 4.6. Electrocardiography
- 4.6.1. Key Market Trends, Growth Factors and Opportunities
- 4.6.2. Market Size and Forecast, By Region
- 4.6.3. Market Share Analysis, By Country
- 4.7. Echocardiography
- 4.7.1. Key Market Trends, Growth Factors and Opportunities
- 4.7.2. Market Size and Forecast, By Region
- 4.7.3. Market Share Analysis, By Country
- 4.8. Others
- 4.8.1. Key Market Trends, Growth Factors and Opportunities
- 4.8.2. Market Size and Forecast, By Region
- 4.8.3. Market Share Analysis, By Country
CHAPTER 5: ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By End User
- 5.2. Hospitals And Clinics
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Ambulatory Surgery Centers
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Diagnostic Laboratories And Imaging Centers
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
- 5.5. Others
- 5.5.1. Key Market Trends, Growth Factors and Opportunities
- 5.5.2. Market Size and Forecast, By Region
- 5.5.3. Market Share Analysis, By Country
CHAPTER 6: ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY REGION
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Region
- 6.2. North America
- 6.2.1. Key Market Trends and Opportunities
- 6.2.2. Market Size and Forecast, By Technology
- 6.2.3. Market Size and Forecast, By End User
- 6.2.4. Market Size and Forecast, By Country
- 6.2.5. U.S. Acute Ischemic Stroke Diagnosis Market
- 6.2.5.1. Market Size and Forecast, By Technology
- 6.2.5.2. Market Size and Forecast, By End User
- 6.2.6. Canada Acute Ischemic Stroke Diagnosis Market
- 6.2.6.1. Market Size and Forecast, By Technology
- 6.2.6.2. Market Size and Forecast, By End User
- 6.2.7. Mexico Acute Ischemic Stroke Diagnosis Market
- 6.2.7.1. Market Size and Forecast, By Technology
- 6.2.7.2. Market Size and Forecast, By End User
- 6.3. Europe
- 6.3.1. Key Market Trends and Opportunities
- 6.3.2. Market Size and Forecast, By Technology
- 6.3.3. Market Size and Forecast, By End User
- 6.3.4. Market Size and Forecast, By Country
- 6.3.5. Germany Acute Ischemic Stroke Diagnosis Market
- 6.3.5.1. Market Size and Forecast, By Technology
- 6.3.5.2. Market Size and Forecast, By End User
- 6.3.6. France Acute Ischemic Stroke Diagnosis Market
- 6.3.6.1. Market Size and Forecast, By Technology
- 6.3.6.2. Market Size and Forecast, By End User
- 6.3.7. UK Acute Ischemic Stroke Diagnosis Market
- 6.3.7.1. Market Size and Forecast, By Technology
- 6.3.7.2. Market Size and Forecast, By End User
- 6.3.8. Italy Acute Ischemic Stroke Diagnosis Market
- 6.3.8.1. Market Size and Forecast, By Technology
- 6.3.8.2. Market Size and Forecast, By End User
- 6.3.9. Spain Acute Ischemic Stroke Diagnosis Market
- 6.3.9.1. Market Size and Forecast, By Technology
- 6.3.9.2. Market Size and Forecast, By End User
- 6.3.10. Rest of Europe Acute Ischemic Stroke Diagnosis Market
- 6.3.10.1. Market Size and Forecast, By Technology
- 6.3.10.2. Market Size and Forecast, By End User
- 6.4. Asia-Pacific
- 6.4.1. Key Market Trends and Opportunities
- 6.4.2. Market Size and Forecast, By Technology
- 6.4.3. Market Size and Forecast, By End User
- 6.4.4. Market Size and Forecast, By Country
- 6.4.5. Japan Acute Ischemic Stroke Diagnosis Market
- 6.4.5.1. Market Size and Forecast, By Technology
- 6.4.5.2. Market Size and Forecast, By End User
- 6.4.6. China Acute Ischemic Stroke Diagnosis Market
- 6.4.6.1. Market Size and Forecast, By Technology
- 6.4.6.2. Market Size and Forecast, By End User
- 6.4.7. India Acute Ischemic Stroke Diagnosis Market
- 6.4.7.1. Market Size and Forecast, By Technology
- 6.4.7.2. Market Size and Forecast, By End User
- 6.4.8. Australia Acute Ischemic Stroke Diagnosis Market
- 6.4.8.1. Market Size and Forecast, By Technology
- 6.4.8.2. Market Size and Forecast, By End User
- 6.4.9. South Korea Acute Ischemic Stroke Diagnosis Market
- 6.4.9.1. Market Size and Forecast, By Technology
- 6.4.9.2. Market Size and Forecast, By End User
- 6.4.10. Rest of Asia-Pacific Acute Ischemic Stroke Diagnosis Market
- 6.4.10.1. Market Size and Forecast, By Technology
- 6.4.10.2. Market Size and Forecast, By End User
- 6.5. LAMEA
- 6.5.1. Key Market Trends and Opportunities
- 6.5.2. Market Size and Forecast, By Technology
- 6.5.3. Market Size and Forecast, By End User
- 6.5.4. Market Size and Forecast, By Country
- 6.5.5. Brazil Acute Ischemic Stroke Diagnosis Market
- 6.5.5.1. Market Size and Forecast, By Technology
- 6.5.5.2. Market Size and Forecast, By End User
- 6.5.6. Saudi Arabia Acute Ischemic Stroke Diagnosis Market
- 6.5.6.1. Market Size and Forecast, By Technology
- 6.5.6.2. Market Size and Forecast, By End User
- 6.5.7. South Africa Acute Ischemic Stroke Diagnosis Market
- 6.5.7.1. Market Size and Forecast, By Technology
- 6.5.7.2. Market Size and Forecast, By End User
- 6.5.8. Rest of LAMEA Acute Ischemic Stroke Diagnosis Market
- 6.5.8.1. Market Size and Forecast, By Technology
- 6.5.8.2. Market Size and Forecast, By End User
CHAPTER 7: COMPETITIVE LANDSCAPE
- 7.1. Introduction
- 7.2. Top Winning Strategies
- 7.3. Product Mapping of Top 10 Player
- 7.4. Competitive Dashboard
- 7.5. Competitive Heatmap
- 7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
- 8.1. Koninklijke Philips N.V.
- 8.1.1. Company Overview
- 8.1.2. Key Executives
- 8.1.3. Company Snapshot
- 8.1.4. Operating Business Segments
- 8.1.5. Product Portfolio
- 8.1.6. Business Performance
- 8.1.7. Key Strategic Moves and Developments
- 8.2. GE Healthcare
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Operating Business Segments
- 8.2.5. Product Portfolio
- 8.2.6. Business Performance
- 8.2.7. Key Strategic Moves and Developments
- 8.3. Canon Inc.
- 8.3.1. Company Overview
- 8.3.2. Key Executives
- 8.3.3. Company Snapshot
- 8.3.4. Operating Business Segments
- 8.3.5. Product Portfolio
- 8.3.6. Business Performance
- 8.3.7. Key Strategic Moves and Developments
- 8.4. Simens
- 8.4.1. Company Overview
- 8.4.2. Key Executives
- 8.4.3. Company Snapshot
- 8.4.4. Operating Business Segments
- 8.4.5. Product Portfolio
- 8.4.6. Business Performance
- 8.4.7. Key Strategic Moves and Developments
- 8.5. Terumo Corporation
- 8.5.1. Company Overview
- 8.5.2. Key Executives
- 8.5.3. Company Snapshot
- 8.5.4. Operating Business Segments
- 8.5.5. Product Portfolio
- 8.5.6. Business Performance
- 8.5.7. Key Strategic Moves and Developments
- 8.6. Stryker
- 8.6.1. Company Overview
- 8.6.2. Key Executives
- 8.6.3. Company Snapshot
- 8.6.4. Operating Business Segments
- 8.6.5. Product Portfolio
- 8.6.6. Business Performance
- 8.6.7. Key Strategic Moves and Developments
- 8.7. Fujifilm Holdings Corporation
- 8.7.1. Company Overview
- 8.7.2. Key Executives
- 8.7.3. Company Snapshot
- 8.7.4. Operating Business Segments
- 8.7.5. Product Portfolio
- 8.7.6. Business Performance
- 8.7.7. Key Strategic Moves and Developments
- 8.8. Samsung Electronics Co. Ltd
- 8.8.1. Company Overview
- 8.8.2. Key Executives
- 8.8.3. Company Snapshot
- 8.8.4. Operating Business Segments
- 8.8.5. Product Portfolio
- 8.8.6. Business Performance
- 8.8.7. Key Strategic Moves and Developments
- 8.9. F. Hoffmann-La Roche Ltd
- 8.9.1. Company Overview
- 8.9.2. Key Executives
- 8.9.3. Company Snapshot
- 8.9.4. Operating Business Segments
- 8.9.5. Product Portfolio
- 8.9.6. Business Performance
- 8.9.7. Key Strategic Moves and Developments
- 8.10. Boehringer Ingelheim International GmbH
- 8.10.1. Company Overview
- 8.10.2. Key Executives
- 8.10.3. Company Snapshot
- 8.10.4. Operating Business Segments
- 8.10.5. Product Portfolio
- 8.10.6. Business Performance
- 8.10.7. Key Strategic Moves and Developments
